
Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+2.70%
+16.27%
-6.18%
+21.12%
Most Trending
+2.70%
+16.27%
-6.18%
+21.12%
05 Nov 2025$LMND is absolutely on fire today, climbing 34% after posting a strong Q3 earnings report. Lemonade delivered a GAAP EPS of -$0.51, beating estimates by $0.19, with revenue of $194.5M topping forecasts by nearly $9.5M. The company also raised its forward guidance, signaling optimism about growth ahead. Traders are clearly reacting to both the earnings beat and momentum, pushing the stock higher even as the RSI enters overbought territory.
$TDC surged 32% following Teradata’s impressive Q3 results and a raised full-year EPS guidance. Revenue and earnings beat analyst expectations, and the market is rewarding the company for its strong positioning in the enterprise data analytics space. Elevated trading volume suggests that institutional investors are stepping in, and the bullish sentiment is carrying through from pre-market trading into the session.
$SEDG climbed 29% as SolarEdge Technologies posted better-than-expected earnings despite cautionary guidance for Q4. Non-GAAP EPS of -$0.31 beat by $0.11, and revenue of $340.18M topped estimates. Improved margins and resilience against tariffs drove investor enthusiasm, while volume spikes indicate strong short-term interest from momentum traders.
$BW jumped 28% after Babcock & Wilcox released multiple strategic announcements, including a $1.5 billion AI data initiative. The after-hours surge carried into the trading session, reflecting market excitement around the company’s ambitious growth plans. Investors are clearly intrigued by the potential transformation, and the stock has become a magnet for speculative buying.
$DTCK continues its upward streak, climbing 24% with a fifth consecutive day of gains. Momentum traders are driving this rally, and consistent buying interest is highlighting optimism around the company’s near-term prospects. While specific catalysts weren’t disclosed, the stock’s streak itself is creating a self-reinforcing positive sentiment among market participants.
On the downside,
$PRGO dropped 25% despite beating Q3 earnings estimates. Perrigo reported a non-GAAP EPS of $0.80, but revenue fell short by $60M, and the company revised its 2025 EPS outlook while launching a strategic review of its infant formula unit. Investors appear concerned about soft demand and the potential restructuring impact, sending the stock sharply lower.
$SLNO fell 26% after reporting Q3 results, marking its fifth consecutive day of losses. Soleno Therapeutics’ performance raised caution among traders, with persistent selling pressure reflecting concerns over the company’s near-term execution and market traction.
$TREX dropped 31% after analysts turned bearish on the stock, highlighting downgrades that weigh on sentiment. The sharp decline comes amid concerns about growth and valuation, prompting a significant pullback even as broader markets remained supportive.
$BHVN tumbled 40%, continuing a multi-day slide. The stock has now lost momentum for five straight sessions, with heavy selling likely reflecting disappointing results or renewed concerns over strategic execution and competitive pressures.
$RUBI saw the steepest decline, dropping nearly 50% after a 10-day losing streak. The stock’s dramatic sell-off underscores deep-seated investor worries, likely tied to fundamental challenges or a continued erosion of confidence. Such a streak signals extreme caution for anyone considering entering the trade.
11:08 AM
Yesterday at 08:54
Yesterday at 08:27
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Find out what 10,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Real-time stock market updates
Expert stock analysis
Investment strategies
Top stock recommendations
Trading signals and opportunities
Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.